You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 7, July 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Effects of Olive Oil on {omega}3 Fatty Acids and Mood Disorders

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Stoll et al1 on the benefits of {omega}3 fatty acids on the short-term course of illness in bipolar disorder. The treatment group in this trial received the {omega}3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid. The results are therefore consistent with the membrane phospholipid model of Horrobin,2 dating from more than 20 years ago, and with the finding by both Peet and colleagues3-4 and Maes and colleagues5 of depletion of {omega}3 polyunsaturated fatty acid levels (particularly docosahexaenoic acid) in erythrocyte membranes of patients with depressive disorder; indeed, the first group has also found that severity of unipolar depression negatively correlates with both erythrocyte membrane {omega}3 polyunsaturated fatty acid levels and dietary intake of these fatty acids.6

However, we would question the use of olive oil as a placebo in the present study. Dietary intake of olive oil may itself lead to an . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Crone et al.
Psychosomatics 2001;42:285-299.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.